Literature DB >> 6583691

Serotonin binds specifically and saturably to an actin-like protein isolated from rat brain synaptosomes.

D H Small, R J Wurtman.   

Abstract

A soluble serotonin-binding protein was identified in a high-speed supernatant fraction of an osmotically shocked rat brain synaptosome (P2) preparation. The binding of serotonin was saturable (Bmax = 6.0 nmol per mg of protein) and was specific for serotonin and a few structurally related compounds including dopamine and norepinephrine. Binding of serotonin (1 microM) was inhibited approximately equal to 40% by chlorpromazine (10 microM). The affinity of serotonin for the binding protein was low in the crude extract (Kd = 1.7 X 10(-3)M). However, on purification by chromatography on a column of phenothiazine agarose, a higher affinity (Kd = 10(-5) M) binding component was also observed. The purified protein was greatly enriched in a polypeptide of Mr of 43,000 that comigrated on polyacrylamide gel with skeletal muscle actin. Muscle actin also bound serotonin, and the binding to actin was similar to that of the purified protein in both the specificity of the binding and the affinity for serotonin. It is likely that the serotonin-binding protein is identical to cytoplasmic G-actin or an actin-like protein of similar molecular weight.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6583691      PMCID: PMC344959          DOI: 10.1073/pnas.81.3.959

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

Review 1.  Action of drugs on microtubules.

Authors:  L Wilson
Journal:  Life Sci       Date:  1975-08-01       Impact factor: 5.037

2.  Stereospecificity of interaction of neuroleptic drugs with neurotransmitters and correlation with clinical potency.

Authors:  S J Enna; J P Bennett; D R Burt; I Creese; S H Snyder
Journal:  Nature       Date:  1976-09-23       Impact factor: 49.962

3.  Serotonin and lysergic acid diethylamide binding in rat brain membranes: relationship to postsynaptic serotonin receptors.

Authors:  J P Bennett; S H Snyder
Journal:  Mol Pharmacol       Date:  1976-05       Impact factor: 4.436

4.  Serotonin binding protein:enhancement of binding by Fe2+ and inhibition of binding by drugs.

Authors:  H Tamir; A Klein; M M Rapport
Journal:  J Neurochem       Date:  1976-05       Impact factor: 5.372

5.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

6.  Actomyosin-like protein in brain.

Authors:  S Berl; S Puszkin; W J Nicklas
Journal:  Science       Date:  1973-02-02       Impact factor: 47.728

Review 7.  Actin and myosin and cell movement.

Authors:  T D Pollard; R R Weihing
Journal:  CRC Crit Rev Biochem       Date:  1974-01

8.  Muscle-like contractile proteins and tubulin in synaptosomes.

Authors:  A L Blitz; R E Fine
Journal:  Proc Natl Acad Sci U S A       Date:  1974-11       Impact factor: 11.205

9.  Phenothiazine drugs: structure-activity relationships explained by a conformation that mimics dopamine.

Authors:  A P Feinberg; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1975-05       Impact factor: 11.205

10.  Is the serotonin binding protein (SBP) a soluble storage form for serotonin?

Authors:  H Tamir; M M Rapport
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1976-02
View more
  3 in total

Review 1.  Embryonal central neuroepithelial tumors: current concepts and future challenges.

Authors:  S R Vandenberg; M M Herman; L J Rubinstein
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

2.  Serotonin: an overlooked regulator of endocytosis and endosomal sorting?

Authors:  Gregory Redpath; Nikita Deo
Journal:  Biol Open       Date:  2022-01-25       Impact factor: 2.422

3.  Serotonylation of vascular proteins important to contraction.

Authors:  Stephanie W Watts; Jessica R C Priestley; Janice M Thompson
Journal:  PLoS One       Date:  2009-05-25       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.